Dr. Sriranjani Parthasarathy Padmanabhan, MD

Dr. Padmanabhan practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Padmanabhan's NPI, 1750545141, was assigned on July 15, 2008. Dr. Padmanabhan graduated from University of Rochester Medical Center in 2008. Dr. Padmanabhan's California license number on file is A138616.

Dr. Padmanabhan's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Padmanabhan's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Padmanabhan is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Padmanabhan to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Padmanabhan practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Padmanabhan's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Padmanabhan is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Padmanabhan's licenses on file in 5 states: California, Massachusetts, Alaska, Georgia and Pennsylvania.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, glaucoma, glaucoma surgery, inflammation of iris, secondary membranaous cataract surgery and surgical retina and vitreous procedures among the conditions Dr. Padmanabhan treats.

CMS data shows 687 Medicare services from Dr. Padmanabhan across 12 procedure codes in 2024, for 293 Medicare patients. Medicare paid $75,231 for them.

CMS counts 293 Medicare patients who saw Dr. Padmanabhan in 2024. The largest group is 65 to 74, with 123 patients. 70% of them have high blood pressure, and 63% have high cholesterol. 59% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Padmanabhan's median patient age at 74, with 51% women.

In 2024, Dr. Padmanabhan wrote 1,914 Medicare Part D claims for 372 patients. 60% of them were for generic drugs. CMS names the drug for 1,802 of them, across 22 drugs with 11 or more claims each, at $153,608 in total drug cost. In 2023, CMS named 1,747 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Padmanabhan for performance year 2024, reported as part of a group. Dr. Padmanabhan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 77 procedures of cataract surgery by Dr. Padmanabhan, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Padmanabhan, published from 2022 to 2024. 2023 was the busiest year, with 3. Dr. Padmanabhan's most frequent co-authors are Tessnim R. Ahmad, MD, Lawrence Chan and Matilda F. Chan, MD, PhD.

Dmand AI links Dr. Padmanabhan to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Patient Satisfaction and Medication Adherence.

CMS Open Payments shows 17 general payments to Dr. Padmanabhan from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Bausch Health Americas, Inc. paid the most, $3,702.

Dr. Padmanabhan graduated from University of Rochester Medical Center in 2008.

Dr. Padmanabhan is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.